The role of gluten challenge in the diagnosis of celiac disease: a review

References

• Lindfors K, Ciacci C, Kurppa K, et al. Coeliac disease. Nat Rev Dis Primers. 2019;5(1):3. DOI:10.1038/s41572-018-0054-z
   PubMed Web of Science ®Google Scholar
• Husby S, Koletzko S, Ilma Korponay-Szabó I, et al. European society paediatric gastroenterology, hepatology and nutrition guidelines for diagnosing coeliac disease 2020. J Pediatr Gastroenterol Nutr. 2020;70(1):141–156. DOI:10.1097/MPG.0000000000002497
   PubMed Web of Science ®Google Scholar
• Fuchs V, Kurppa K, Huhtala H, et al. Serology-based criteria for adult coeliac disease have excellent accuracy across the range of pre-test probabilities. Aliment Pharmacol Ther. 2019;49(3):277–284. DOI:10.1111/apt.15109
   PubMed Web of Science ®Google Scholar
• Penny H, Raju S, Lau M, et al. Accuracy of a no-biopsy approach for the diagnosis of coeliac disease across different adult cohorts. Gut. 2021;70(5):876–883. DOI:10.1136/gutjnl-2020-320913
   PubMed Web of Science ®Google Scholar
• McNeish A, Harms H, Rey J, et al. The diagnosis of coeliac disease. A commentary on the current practices of members of the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN). Arch Dis Child. 1979;54(10):783–786. DOI:10.1136/adc.54.10.783
   PubMed Web of Science ®Google Scholar
• Revised criteria for diagnosis of coeliac disease. report of working group of European society of paediatric gastroenterology and nutrition. Arch Dis Child. 1990;65(8):909–911. DOI:10.1136/adc.65.8.909
   PubMed Web of Science ®Google Scholar
• Husby S, Koletzko S, Korponay-Szabó IR. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–160.
   PubMed Web of Science ®Google Scholar
• Popp A, Kivelä L, Fuchs V, et al. Diagnosing celiac disease: towards wide-scale screening and serology-based criteria? Gastroenterol Res Pract. 2019;2019:1–10.
   Web of Science ®Google Scholar
• Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United Eur Gastroenterol J. 2019;7(5):583–613. DOI:10.1177/2050640619844125
   PubMed Web of Science ®Google Scholar
• Kivelä L, Caminero A, Leffler D, et al. Current and emerging therapies for coeliac disease. Nat Rev Gastroenterol Hepatol. 2021;18(3):181–195. DOI:10.1038/s41575-020-00378-1
   PubMed Web of Science ®Google Scholar
• Leinonen H, Kivelä L, Lähdeaho ML, et al. Daily life restrictions are common and associated with health concerns and dietary challenges in adult celiac disease patients diagnosed in childhood. Nutrients. 2019;11(8):1718. DOI:10.3390/nu11081718
   PubMed Web of Science ®Google Scholar
• Kivelä L, Eurén A, Repo M, et al. Coexisting type 1 diabetes, persistent symptoms, and financial issues associate with poorer adherence to a gluten-free diet in celiac disease after transition from pediatrics to adult care. Front Nutr. 2022;9:883220.
   PubMed Web of Science ®Google Scholar
• Green P, Paski S, Ko C, et al. AGA clinical practice update on management of refractory celiac disease: expert review. Gastroenterology. 2022;163(5):1461–1469.
   PubMed Web of Science ®Google Scholar
• Gaesser G, Angadi S. Navigating the gluten-free boom. JAAPA. 2015;28(8):1–7.
   Google Scholar
• Lebwohl B, Cao Y, Zong G, et al. Long term gluten consumption in adults without celiac disease and risk of coronary heart disease: prospective cohort study. BMJ. 2017;357:1892.
   PubMedGoogle Scholar
• Jones A. The gluten-free diet: fad or necessity? Diabetes Spectr. 2017;30(2):118–123.
   PubMedGoogle Scholar
• Hakola L, Miettinen ME, Syrjälä E, et al. Association of cereal, gluten, and dietary fiber intake with islet autoimmunity and type 1 diabetes. JAMA Pediatr. 2019;173(10):953–960. DOI:10.1001/jamapediatrics.2019.2564
   PubMed Web of Science ®Google Scholar
• Corazza G, Villanacci V. Coeliac disease. J Clin Pathol. 2005;58(6):573–574.
   PubMed Web of Science ®Google Scholar
• Ravelli A, Villanacci V, Monfredini C, et al. How patchy is patchy villous atrophy? Distribution pattern of histological lesions in the duodenum of children with celiac disease. Am J Gastroenterol. 2010;105(9):2103–2110. DOI:10.1038/ajg.2010.153
   PubMed Web of Science ®Google Scholar
• Taavela J, Koskinen O, Huhtala H, et al. Validation of morphometric analyses of small-intestinal biopsy readouts in celiac disease. PLoS ONE. 2013;8(10):e76163. DOI:10.1371/journal.pone.0076163
   PubMed Web of Science ®Google Scholar
• Werkstetter K, Korponay-Szabó IR, Popp A, et al. Accuracy in diagnosis of celiac disease without biopsies in clinical practice. Gastroenterology. 2017;153(4):924–935. DOI:10.1053/j.gastro.2017.06.002
   PubMed Web of Science ®Google Scholar
• Gustafsson I, Repo M, Popp A, et al. Prevalence and diagnostic outcomes of children with duodenal lesions and negative celiac serology. Dig Liver Dis. 2020;52(3):289–295. DOI:10.1016/j.dld.2019.11.011
   PubMedGoogle Scholar
• Aziz I, Peerally M, Barnes JH, et al. The clinical and phenotypical assessment of seronegative villous atrophy; a prospective UK centre experience evaluating 200 adult cases over a 15-year period (2000-2015). Gut. 2017;66(9):1563–1572. DOI:10.1136/gutjnl-2016-312271
   PubMed Web of Science ®Google Scholar
• Ylönen V, Lindfors K, Repo M, et al. Non-biopsy serology-based diagnosis of celiac disease in adults is accurate with different commercial kits and pre-test probabilities. Nutrients. 2020;12(9):2736. DOI:10.3390/nu12092736
   PubMed Web of Science ®Google Scholar
• Schiepatti A, Rej A, Maimaris S, et al. Clinical classification and long-term outcomes of seronegative coeliac disease: a 20-year multicentre follow-up study. Aliment Pharmacol Ther. 2021;54(10):1278–1289. DOI:10.1111/apt.16599
   PubMed Web of Science ®Google Scholar
• Husby S, Murray J, Katzka D. AGA clinical practice update on diagnosis and monitoring of celiac disease: changing utility of serology and histologic measures: expert review. Gastroenterology. 2019;156(4):885–889.
   PubMed Web of Science ®Google Scholar
• Kaukinen K, Partanen J, Mäki M, et al. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol. 2002;97(3):695–699.
   PubMed Web of Science ®Google Scholar
• Rubio-Tapia A, Hill I, Kelly C, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108(5):656–676. DOI:10.1038/ajg.2013.79
   PubMed Web of Science ®Google Scholar
• Gatti S, Rossi M, Alfonsi S, et al. Beyond the intestinal celiac mucosa: diagnostic role of anti-TG2 deposits, a systematic review. Front Med. 2014;1:9.
   Google Scholar
• Koskinen O, Collin P, Lindfors K, et al. Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease. J Clin Gastroenterol. 2010;44(7):483–488. DOI:10.1097/MCG.0b013e3181b64557
   PubMed Web of Science ®Google Scholar
• Salmi T, Collin P, Korponay-Szabó IR, et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut. 2006;55(12):1746–1753. DOI:10.1136/gut.2005.071514
   PubMed Web of Science ®Google Scholar
• Mearin L, Agardh D, Antunes H, et al. ESPGHAN position paper on management and follow-up of children and adolescents with celiac disease. J Pediatr Gastroenterol Nutr. 2022;75(3):369–386. DOI:10.1097/MPG.0000000000003540
   PubMed Web of Science ®Google Scholar
• van Overbeek F, Uil-Dieterman I, Mol I, et al. The daily gluten intake in relatives of patients with coeliac disease compared with that of the general Dutch population. Eur J Gastroenterol Hepatol. 1997;9(11):1097–1099. DOI:10.1097/00042737-199711000-00013
   PubMed Web of Science ®Google Scholar
• Holm K, Mäki M, Vuolteenaho N, et al. Oats in the treatment of childhood coeliac disease: a 2-year controlled trial and a long-term clinical follow-up study. Aliment Pharmacol Ther. 2006;23(10):1463–1472. DOI:10.1111/j.1365-2036.2006.02908.x
   PubMed Web of Science ®Google Scholar
• Mäki M, Lähdeaho ML, Hällström O, et al. Postpubertal gluten challenge in coeliac disease. Arch Dis Child. 1989;64(11):1604–1607.
   PubMed Web of Science ®Google Scholar
• Korponay-Szabó IR, Kovács JM, Lörincz M, et al. Prospective significance of antiendomysium antibody positivity in subsequently verified celiac disease. J Pediatr Gastroenterol Nutr. 1997;25(1):56–63. DOI:10.1097/00005176-199707000-00009
   PubMed Web of Science ®Google Scholar
• Koskinen O, Villanen M, Korponay-Szabo IR, et al. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease. J Pediatr Gastroenterol Nutr. 2009;48(5):559–565. DOI:10.1097/MPG.0b013e3181668635
   PubMed Web of Science ®Google Scholar
• Kurppa K, Koskinen O, Collin P, et al. Changing phenotype of celiac disease after long-term gluten exposure. J Pediatr Gastroenterol Nutr. 2008;47(4):500–503. DOI:10.1097/MPG.0b013e31817d8120
   PubMed Web of Science ®Google Scholar
• Hardy M, Girardin A, Pizzey C, et al. Consistency in polyclonal T-cell responses to gluten between children and adults with celiac disease. Gastroenterology. 2015;149(6):1541–1552. DOI:10.1053/j.gastro.2015.07.013
   PubMed Web of Science ®Google Scholar
• Wahab P, Crusius J, Meijer J, et al. Gluten challenge in borderline gluten-sensitive enteropathy. Am J Gastroenterol. 2001;96(5):1464–1469.
   PubMed Web of Science ®Google Scholar
• Cornell H, Macrae F, Melny J, et al. Enzyme therapy for management of coeliac disease. Scand J Gastroenterol. 2005;40(11):1304–1312. DOI:10.1080/00365520510023855
   PubMed Web of Science ®Google Scholar
• Tye-Din J, Stewart J, Dromey J, et al. Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease. Sci Transl Med. 2010;2(41):41ra51. DOI:10.1126/scitranslmed.3001012
   PubMed Web of Science ®Google Scholar
• Brottveit M, Ráki M, Bergseng E, et al. Assessing possible celiac disease by an HLA-DQ2-gliadin tetramer test. Am J Gastroenterol. 2011;106(7):1318–1324. DOI:10.1038/ajg.2011.23
   PubMed Web of Science ®Google Scholar
• Daveson J, Jones D, Gaze S, et al. Effect of hookworm infection on wheat challenge in celiac disease–a randomised double-blinded placebo controlled trial. PLoS ONE. 2011;6(3):e17366. DOI:10.1371/journal.pone.0017366
   PubMed Web of Science ®Google Scholar
• Beitnes AC, Ráki M, Brottveit M, et al. Rapid accumulation of CD14+CD11c+ dendritic cells in gut mucosa of celiac disease after in vivo gluten challenge. PLoS ONE. 2012;7(3):e33556. DOI:10.1371/journal.pone.0033556
   PubMed Web of Science ®Google Scholar
• Camarca A, Radano G, Di Mase R, et al. Short wheat challenge is a reproducible in-vivo assay to detect immune response to gluten. Clin Exp Immunol. 2012;169(2):129–136. DOI:10.1111/j.1365-2249.2012.04597.x
   PubMed Web of Science ®Google Scholar
• Leffler D, Kelly C, Abdallah H, et al. A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am J Gastroenterol. 2012;107(10):1554–1562. DOI:10.1038/ajg.2012.211
   PubMed Web of Science ®Google Scholar
• Brottveit M, Beitnes A, Tollefsen S, et al. Mucosal cytokine response after short-term gluten challenge in celiac disease and non-celiac gluten sensitivity. Am J Gastroenterol. 2013;108(5):842–850. DOI:10.1038/ajg.2013.91
   PubMed Web of Science ®Google Scholar
• Leffler D, Schuppan D, Pallav K, et al. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut. 2013;62(7):996–1004. DOI:10.1136/gutjnl-2012-302196
   PubMed Web of Science ®Google Scholar
• Tack G, van de Water J, Bruins M, et al. Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study. World J Gastroenterol. 2013;19(35):5837–5847. DOI:10.3748/wjg.v19.i35.5837
   PubMed Web of Science ®Google Scholar
• López-Palacios N, Pascual V, Castaño M, et al. Evaluation of T cells in blood after a short gluten challenge for coeliac disease diagnosis. Dig Liver Dis. 2018;50(11):1183–1188. DOI:10.1016/j.dld.2018.04.014
   PubMedGoogle Scholar
• Sarna V, Skodje G, Reims H, et al. HLA-DQ: gluten tetramer test in blood gives better detection of coeliac patients than biopsy after 14-day gluten challenge. Gut. 2018;67(9):1606–1613. DOI:10.1136/gutjnl-2017-314461
   PubMed Web of Science ®Google Scholar
• Tye-Din J, Daveson J, Ee H, et al. Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease. Aliment Pharmacol Ther. 2019;50(8):901–910. DOI:10.1111/apt.15477
   PubMed Web of Science ®Google Scholar
• Daveson J, Tye-Din J, Goel G, et al. Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. Aliment Pharmacol Ther. 2020;51(2):244–252. DOI:10.1111/apt.15551
   PubMed Web of Science ®Google Scholar
• Goel G, Daveson J, Hooi C, et al. Serum cytokines elevated during gluten-mediated cytokine release in coeliac disease. Clin Exp Immunol. 2020;199(1):68–78. DOI:10.1111/cei.13369
   PubMed Web of Science ®Google Scholar
• Yohannes D, de Kauwe A, Kaukinen K, et al. Effects of in vivo gluten challenge on PBMC gene expression profiles in diet treated celiac disease. Front Immunol. 2020;11:594243.
   PubMed Web of Science ®Google Scholar
• Leonard M, Silvester J, Leffler D, et al. Evaluating responses to gluten challenge: a randomized, double-blind, 2-dose gluten challenge trial. Gastroenterology. 2021;160(3):720–733. DOI:10.1053/j.gastro.2020.10.040
   PubMed Web of Science ®Google Scholar
• Stamnaes J, Stray D, Stensland M, et al. In well-treated celiac patients low-level mucosal inflammation predicts response to 14-day gluten challenge. Adv Sci. 2021;8(4):2003526. DOI:10.1002/advs.202003526
   Web of Science ®Google Scholar
• Pyle G, Paaso B, Anderson B, et al. Low-dose gluten challenge in celiac sprue: malabsorptive and antibody responses. Clin Gastroenterol Hepatol. 2005;3(7):679–686. DOI:10.1016/S1542-3565(05)00365-4
   PubMed Web of Science ®Google Scholar
• Lähdeaho ML, Mäki M, Laurila K, et al. Small-bowel mucosal changes and antibody responses after low- and moderate-dose gluten challenge in celiac disease. BMC Gastroenterol. 2011;11:129.
   PubMed Web of Science ®Google Scholar
• Kelly C, Green PH, Murray JA, et al. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study. Aliment Pharmacol Ther. 2013;37(2):252–262. DOI:10.1111/apt.12147
   PubMed Web of Science ®Google Scholar
• Lähdeaho ML, Kaukinen K, Laurila K, et al. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease. Gastroenterology. 2014;146(7):1649–1658. DOI:10.1053/j.gastro.2014.02.031
   PubMed Web of Science ®Google Scholar
• Lähdeaho ML, Scheinin M, Vuotikka P, et al. Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study. Lancet Gastroenterol Hepatol. 2019;4(12):948–959. DOI:10.1016/S2468-1253(19)30264-X
   PubMed Web of Science ®Google Scholar
• Taavela J, Viiri K, Popp A, et al. Histological, immunohistochemical and mRNA gene expression responses in coeliac disease patients challenged with gluten using PAXgene fixed paraffin-embedded duodenal biopsies. BMC Gastroenterol. 2019;19(1):189. DOI:10.1186/s12876-019-1089-7
   PubMed Web of Science ®Google Scholar
• Dotsenko V, Oittinen M, Taavela J, et al. Genome-wide transcriptomic analysis of intestinal mucosa in celiac disease patients on a gluten-free diet and postgluten challenge. Cell Mol Gastroenterol Hepatol. 2021;11(1):13–32. DOI:10.1016/j.jcmgh.2020.07.010
   PubMed Web of Science ®Google Scholar
• Schuppan D, Mäki M, Lundin K, et al. A randomized trial of a transglutaminase 2 inhibitor for celiac disease. N Engl J Med. 2021;385(1):35–45. DOI:10.1056/NEJMoa2032441
   PubMed Web of Science ®Google Scholar
• Murray JA, Syage J, Wu T, et al. Latiglutenase protects the mucosa and attenuates symptom severity in patients with celiac disease exposed to a gluten challenge. Gastroenterology. 2022;163(6):1510–1521. DOI:10.1053/j.gastro.2022.07.071
   PubMed Web of Science ®Google Scholar
• Silvester J, Kurada S, Szwajcer A, et al. Tests for serum transglutaminase and endomysial antibodies do not detect most patients with celiac disease and persistent villous atrophy on gluten-free diets: a meta-analysis. Gastroenterology. 2017;153(3):689–701. DOI:10.1053/j.gastro.2017.05.015
   PubMed Web of Science ®Google Scholar
• Rostami-Nejad M, Asri N, Olfatifar M, et al. Systematic review and dose-response meta-analysis on the Relationship between different gluten doses and risk of coeliac disease relapse. Nutrients. 2023;15(6):1390. DOI:10.3390/nu15061390
   PubMed Web of Science ®Google Scholar
• Goel G, Tye-Din J, Qiao SW. Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease. Sci Adv. 2019;5(8):eaaw7756.
   PubMed Web of Science ®Google Scholar
• Costantino A, Aversano G, Lasagni G, et al. Diagnostic management of patients reporting symptoms after wheat ingestion. Front Nutr. 2022;9:1007007.
   PubMed Web of Science ®Google Scholar
• Mumolo M, Rettura F, Melissari S, et al. Is gluten the only culprit for non-celiac gluten/wheat sensitivity? Nutrients. 2020;12(12):3785. DOI:10.3390/nu12123785
   PubMed Web of Science ®Google Scholar
• van Megen F, Skodje G, Lergenmuller S, et al. A low FODMAP diet reduces symptoms in treated celiac patients with ongoing symptoms–a randomized controlled trial. Clin Gastroenterol Hepatol. 2022;20(10):2258–2266. DOI:10.1016/j.cgh.2022.01.011
   PubMed Web of Science ®Google Scholar
• Ajamian M, Rosella G, Newnham E, et al. Effect of gluten ingestion and FODMAP restriction on intestinal epithelial integrity in patients with irritable bowel syndrome and self-reported non-coeliac gluten sensitivity. Mol Nutr Food Res. 2021;65(5):e1901275. DOI:10.1002/mnfr.201901275
   PubMed Web of Science ®Google Scholar
• Saadati S, Sadeghi A, Mohaghegh-Shalmani H, et al. Effects of a gluten challenge in patients with irritable bowel syndrome: a randomized single-blind controlled clinical trial. Sci Rep. 2022;12(1):4960. DOI:10.1038/s41598-022-09055-6
   PubMedGoogle Scholar
• Sainsbury A, Sanders D, Ford A. Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11(4):359–365.
   PubMed Web of Science ®Google Scholar
• Zanchi C, Ventura A, Martelossi S, et al. Rapid anti-transglutaminase assay and patient interview for monitoring dietary compliance in celiac disease. Scand J Gastroenterol. 2013;48(6):764–766. DOI:10.3109/00365521.2013.786129
   PubMed Web of Science ®Google Scholar
• Mehta P, Pan Z, Riley M, et al. Adherence to a gluten-free diet: assessment by dietician interview and serology. J Pediatr Gastroenterol Nutr. 2018;66(3):e67–e70.
   PubMed Web of Science ®Google Scholar
• Bannister E, Cameron D, Ng J, et al. Can celiac serology alone be used as a marker of duodenal mucosal recovery in children with celiac disease on a gluten-free diet? Am J Gastroenterol. 2014;109(9):1478–1483. DOI:10.1038/ajg.2014.200
   PubMed Web of Science ®Google Scholar
• Adelman D, Murray J, Wu T, et al. Measuring change in small intestinal histology in patients with celiac disease. Am J Gastroenterol. 2018;113(3):339–347. DOI:10.1038/ajg.2017.480
   PubMed Web of Science ®Google Scholar
• Arguelles-Grande C, Tennyson Lewis S, Green PH, et al. Variability in small bowel histopathology reporting between different pathology practice settings: impact on the diagnosis of coeliac disease. J Clin Pathol. 2012;65(3):242–247.
   PubMed Web of Science ®Google Scholar
• Corazza G, Villanacci V, Zambelli C, et al. Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease. Clin Gastroenterol Hepatol. 2007;5(7):838–843. DOI:10.1016/j.cgh.2007.03.019
   PubMed Web of Science ®Google Scholar
• Mubarak A, Nikkels P, Houwen R, et al. Reproducibility of the histological diagnosis of celiac disease. Scand J Gastroenterol. 2011;46(9):1065–1073.
   PubMed Web of Science ®Google Scholar
• Popp A, Arvola T, Taavela J, et al. Nonbiopsy approach for celiac disease is accurate when using exact duodenal histomorphometry: prospective study in 2 countries. J Clin Gastroenterol. 2021;55(3):227–232. DOI:10.1097/MCG.0000000000001349
   PubMed Web of Science ®Google Scholar
• Kurppa K, Taavela J, Saavalainen P, et al. Novel diagnostic techniques for celiac disease. Expert Rev Gastroenterol Hepatol. 2016;10(7):795–805.
   PubMed Web of Science ®Google Scholar
• Virta J, Hannula M, Tamminen I, et al. X-ray microtomography is a novel method for accurate evaluation of small-bowel mucosal morphology and surface area. Sci Rep. 2020;10(1):13164. DOI:10.1038/s41598-020-69487-w
   PubMed Web of Science ®Google Scholar
• Virta J, Hannula M, Lindfors K, et al. Validation of the X-ray microtomography in the assessment of duodenal morphometry and surface area in celiac disease. Front Immunol. 2022;13:945197.
   PubMed Web of Science ®Google Scholar
• Risnes L, Christophersen A, Dahal-Koirala S, et al. Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease. J Clin Invest. 2018;128(6):2642–2650. DOI:10.1172/JCI98819
   PubMed Web of Science ®Google Scholar
• Kurki A, Kemppainen E, Laurikka P, et al. The use of peripheral blood mononuclear cells in celiac disease diagnosis and treatment. Expert Rev Gastroenterol Hepatol. 2021;15(3):305–316.
   PubMed Web of Science ®Google Scholar
• Anderson R, van Heel D, Tye-Din J, et al. T cells in peripheral blood after gluten challenge in coeliac disease. Gut. 2005;54(9):1217–1223. DOI:10.1136/gut.2004.059998
   PubMed Web of Science ®Google Scholar
• Anderson R, Goel G, Hardy M, et al. Whole blood interleukin-2 release test to detect and characterize rare circulating gluten-specific T cell responses in coeliac disease. Clin Exp Immunol. 2021;204(3):321–334. DOI:10.1111/cei.13578
   PubMed Web of Science ®Google Scholar
• Christophersen A, Ráki M, Bergseng E, et al. Tetramer-visualized gluten-specific CD4+ T cells in blood as a potential diagnostic marker for coeliac disease without oral gluten challenge. United Eur Gastroenterol J. 2014;2(4):268–278. DOI:10.1177/2050640614540154
   PubMed Web of Science ®Google Scholar
• Sarna V, Lundin K, Mørkrid L, et al. HLA-DQ-Gluten tetramer blood test accurately identifies patients with and without celiac disease in absence of gluten consumption. Gastroenterology. 2018;154(4):886–896. DOI:10.1053/j.gastro.2017.11.006
   PubMed Web of Science ®Google Scholar